1. Home
  2. WHG vs ARMP Comparison

WHG vs ARMP Comparison

Compare WHG & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westwood Holdings Group Inc

WHG

Westwood Holdings Group Inc

N/A

Current Price

$18.53

Market Cap

185.2M

Sector

Finance

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$3.80

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WHG
ARMP
Founded
1983
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
185.2M
199.7M
IPO Year
2002
1996

Fundamental Metrics

Financial Performance
Metric
WHG
ARMP
Price
$18.53
$3.80
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $17.50
AVG Volume (30 Days)
7.2K
★ 83.9K
Earning Date
11-05-2026
11-24-2026
Dividend Yield
★ 3.23%
N/A
EPS Growth
★ 203.85
N/A
EPS
★ 0.60
N/A
Revenue
★ $97,762,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$31.41
★ N/A
Revenue Growth
★ 3.21
N/A
52 Week Low
$14.70
$2.75
52 Week High
$20.97
$14.98

Technical Indicators

Market Signals
Indicator
WHG
ARMP
Relative Strength Index (RSI) 43.27 56.00
Support Level $15.70 $3.38
Resistance Level $20.12 $3.96
Average True Range (ATR) 0.53 0.36
MACD -0.03 0.11
Stochastic Oscillator 0.00 92.59

Price Performance

Historical Comparison
WHG
ARMP

About WHG Westwood Holdings Group Inc

Westwood Holdings Group Inc manages investment assets and provides services for clients through subsidiaries. It operates its business through the Advisory and Trust segments. Its Advisory segment provides investment advisory services to corporate retirement plans, public retirement plans, endowments, foundations, individuals and the Westwood Funds, as well as investment sub-advisory services to mutual funds and its trust segment. The Trust segment offers trust and custodial services to its clients and its advisory segment sponsors common trust funds to institutions and high net-worth individuals. It generates maximum revenue from the Advisory segment. Geographically, it derives a majority of its revenue from the United States, and also has its presence in Canada.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: